Myriad Genetics Inc
NASDAQ:MYGN
Myriad Genetics Inc
NASDAQ:MYGN
Price:
3.85
USD
0.79%
Market Cap:
$360m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Myriad Genetics Inc
NASDAQ:MYGN
|
US |
|
Peet Ltd
ASX:PPC
|
AU |
|
ZIM Integrated Shipping Services Ltd
NYSE:ZIM
|
IL |
|
Applovin Corp
NASDAQ:APP
|
US |
|
Knot Offshore Partners LP
NYSE:KNOP
|
UK |
|
Kimco Realty Corp
NYSE:KIM
|
US |
|
Takamatsu Construction Group Co Ltd
TSE:1762
|
JP |
|
Essex Property Trust Inc
NYSE:ESS
|
US |
|
Pultegroup Inc
NYSE:PHM
|
US |
|
Asia Vital Components Co Ltd
TWSE:3017
|
TW |
Wall St Price Targets
MYGN Price Targets Summary
Myriad Genetics Inc
Myriad Genetics Inc
Wall Street analysts forecast MYGN stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MYGN is 6.35 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
Lowest Forecast
Price Target
4.04
USD
5% Upside
Average Forecast
Price Target
6.35
USD
65% Upside
Highest Forecast
Price Target
10.5
USD
173% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYGN's stock price target?
Price Target
6.35
USD
6.35
USD
According to Wall Street analysts, the average 1-year price target for MYGN is 6.35 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
